Royalty Pharma plc (RPRX)

NASDAQ

$57,22

$+0,15

(+0,26%)

Pre-Market

Royalty Pharma plc (RPRX) Live Price Chart

Last updated: ⁦2026-10-12 12:57:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Royalty Pharma plc (RPRX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $57,22, with a market capitalisation of $25,35B and a P/E ratio of 31,10. Over the past 52 weeks, its price has ranged from $35,23 to $64,38. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$25,35B
Open	$57,07
Day's High	$64,38
Day's Low	$0,26
Previous Close	$56,93
Volume	3,00
Average Volume	2,94M
P/E Ratio	31,10
52-Week High	$64,38
52-Week Low	$35,23
Dividend Yield	1,57%
Earnings Date	--

Royalty Pharma plc (RPRX) Pre-Market Stock Price

Royalty Pharma plc (RPRX) is trading at $57,22 in pre-market trading as of 2026-10-12 11:44:00, up 0,51% ($0,29) from the previous close of $56,93

Pre-market trading shows how investors are pricing RPRX before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Royalty Pharma plc (RPRX) 7-Day Stock Price Change

Over the past seven days, Royalty Pharma plc (RPRX) moved from $57,63 to $57,22, representing a decline of 0,71% ($0,41).

The stock traded between $55,13 and $58,40 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 3,04 million shares, up versus the previous seven-day period, indicating higher trading activity.

RPRX 52-Week Price Position

Position in Range: 75,4%

52W Low$35,23

52W High$64,38

RPRX is currently trading at $57,22, placing it 75,4% of the way from its 52-week low of $35,23 to its 52-week high of $64,38. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Royalty Pharma plc (RPRX)?

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

Royalty Pharma plc Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	100
Exchange	NASDAQ
Company Website	https://www.royaltypharma.com

How to Buy Royalty Pharma plc (RPRX) Stock on MEXC

Eligible investors can buy real shares of Royalty Pharma plc (RPRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for RPRX and Place Your Order

Open the RealStocks trading page and search for RPRX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Royalty Pharma plc (RPRX) stock price today?

Royalty Pharma plc (RPRX) is currently trading at $ 57,22, up 0,51% ($0,29) from the previous close of $ 56,93. Intraday prices update in real time during regular trading hours.

2.Is RPRX stock going up or down today?

As of 2026-10-12 11:44:00, RPRX is trading at $ 57,22, up 0,51% ($0,29) from its previous close of $ 56,93. The stock has traded between $ 0,26 and $ 64,38 during today’s regular session. Past price movements do not guarantee future results.

3.What is RPRX pre-market price?

As of 2026-10-12 11:44:00, RPRX is trading at $ 57,22 in pre-market trading, up 0,51% ($0,29) from the previous close of $ 56,93. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is RPRX after-hours price?

As of 2026-10-12 11:44:00, RPRX is trading at $ 57,10 in after-hours trading, up 0,29% ($0,16) from the regular-session close of $ 56,93. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is RPRX stock trading now?

RPRX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does RPRX sit relative to its 52-week high and low?

Over the past 52 weeks, RPRX has traded between a low of $ 35,23 and a high of $ 64,38. At $ 57,22, the stock is positioned 75,4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Royalty Pharma plc in?

Royalty Pharma plc (RPRX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Royalty Pharma plc's market capitalisation and where is it listed?

Royalty Pharma plc is listed on the NASDAQ exchange with a market capitalisation of $ 25,35B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is RPRX valued in terms of P/E ratio and EPS?

RPRX trades at a P/E ratio of 31,10, based on trailing-twelve-month EPS of $ 1,83. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Royalty Pharma plc pay a dividend?

Royalty Pharma plc pays an indicated annual cash dividend of $ 0,90 per share, with a current dividend yield of 1,57% based on the latest share price. Dividend policies are subject to change at the board's discretion.